Kalish Matthew

DKNG insider Kalish Matthew sells 420,000 shares (9.1% of holdings) for $17,971,800 in two transactions at blended avg $42.79

Kalish Matthew executed 2 separate sales totaling 420,000 shares for $17,971,800.00 on 2025-08-11 and 2025-08-12, reducing holdings from 4.61M to 4.19M shares. Across his 5 prior sales at DKNG, only 2 of 5 were well-timed at the 90-day mark, and recent sales in May posted positive 90-day returns while the earlier March sales declined 17.6% to 20.2%. The stock currently trades at $43.10, near the blended sale price of $42.79, and remains down 19.4% from its 52-week high of $53.49 despite a 12.7% gain over the past 90 days. DraftKings reported $1,512,507,000.00 in quarterly revenue with $157,936,000.00 net income, though the company was unprofitable over its most recent full fiscal year, and has shown annual revenue growth of 30.1%. The magnitude of this sale and the mixed historical timing record at this specific ticker warrant monitoring of subsequent price action and broader insider trading patterns.

Kalish Matthew sells 420,000 DKNG shares ($15.9M) across 3 transactions; holds 4.16M post-sale

Kalish Matthew executed 3 separate sales totaling 420,000 shares for $15,895,848.24 ($15.9M) at an average price of $37.85, reducing his holdings by 9.2% to 4.16M shares. His prior DKNG sales on 2025-03-03 and 2025-03-04 (which showed 30-day declines ranging from -18.5% to -23.4%) present a pattern of selling into weakness rather than strength, yet the current stock is up 10.1% over the past 30 days—contradicting the near-term downside trajectory observed in his recent prior trades. The company posted $-33.9M net income on $1.4B quarterly revenue and 30.1% annual revenue growth, indicating high-growth operations that have not yet achieved profitability; the stock currently sits -29.6% from its 52-week high of $53.49, suggesting the insider is liquidating a substantial portion of his position near recent depressed valuation levels rather than during prior peaks.

Matthew Kalish sold 420,000 shares for $17.6M across 7 transactions on Mar 3–4, 2025 at $41.97 blended average.

Matthew Kalish executed 7 separate sales totaling 420,000 shares for $17,625,625.26, reducing his holdings from 4.56M to 4.14M shares (-9.2%). The sales occurred over two days (March 3–4, 2025) at prices ranging from $39.77 to $44.05, with a blended average of $41.97. The current stock price of $41.30 is -22.8% from the 52-week high of $53.49 and down -7.8% over 90 days, indicating the stock has declined significantly since this transaction. Four of the five prior same-ticker sales at DKNG occurred very recently (2025-02-21, outcomes not yet measurable), suggesting a pattern of recent dispositions. The company remains unprofitable with a $-293.7M net loss in the latest quarter, despite strong +30.1% annual revenue growth, which may contextualize the timing of the sell activity. The insider retains 4.14M shares post-transaction, indicating a substantial ongoing position.

Matthew Kalish sold 587,585 shares ($27.6M) in 4 separate DKNG sales at $45.90–$48.99; stock now at $44.27, down -17.2% from 52-week high.

Matthew Kalish executed 4 separate sales totaling 587,585 shares for $27,645,609.39 at blended average price $47.05, reducing his holdings by 12.5% to 4,121,673 shares. His prior trades at DKNG show 0 of 5 prior sells were well-timed at the 90-day mark—each followed by positive returns, meaning he sold before subsequent gains. The company remains unprofitable with full-year net income of $-293,688,000.00, yet revenue grew 30.1% annually, presenting a classic high-growth-but-unprofitable profile. Stock is currently -17.2% from its 52-week high, trading below his blended sale price of $47.05, creating a narrow window to assess whether this sale precedes further weakness or marks a bottom.